Edition:
United States

Insider Trading: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

253.52USD
24 Jul 2017
Change (% chg)

-- (--)
Prev Close
$253.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
570,826
52-wk High
$261.27
52-wk Low
$184.58

JONES TREVOR M

Institutional Holders

% Shares Owned: 87.81%
# of Holders: 1,542
Total Shares Held: 294,937,416
3 Mo. Net Change: -165,715
# New Positions: 9
# Closed Positions: 10
# Increased Positions: 121
# Reduced Positions: 115
# Net Buyers: 6

Officers & Directors

Name Age Since Current Position

Brenton Saunders

47 2016 Chairman of the Board, President, Chief Executive Officer

Maria Hilado

51 2014 Chief Financial Officer, Executive Vice President

Karen Ling

52 2014 Chief Human Resource Officer, Executive Vice President

A. Robert Bailey

52 2014 Executive Vice President, Chief Legal Officer and Corporate Secretary

William Meury

2015 Executive Vice President and President, Branded Pharma

Paul Navarre

46 2015 Executive Vice President and President, International Brands

Philippe Schaison

54 2015 Executive Vice President and President, Allergan Medical

Robert Stewart

48 2015 Executive Vice President and President, Generic and Global Operations

James D'Arecca

45 2013 Chief Accounting Officer

Christopher Coughlin

64 2016 Lead Independent Director

Paul Bisaro

56 2016 Director

Joseph Boccuzi

2017 Director

Adriane Brown

58 2017 Director

Nesli Basgoz

59 2014 Independent Director

James Bloem

66 2013 Independent Director

Christopher Bodine

61 2013 Independent Director

Catherine Klema

58 2016 Independent Director

Peter McDonnell

58 2015 Independent Director

Patrick O'Sullivan

74 2013 Independent Director

Ron Taylor

68 2013 Independent Director

Fred Weiss

75 2013 Independent Director